Skip to main content
Premium Trial:

Request an Annual Quote

Personal Genome Diagnostics, Human Longevity Ink Oncology Genomics Deal

NEW YORK (GenomeWeb) – Personal Genome Diagnostics and Human Longevity today announced they have signed a collaborative agreement to provide genomic sequencing services to each other.

Human Longevity will have access to PGDx cancer genome analysis panels including CancerSelect, PlasmaSelectCancerXome, METDetec, and CancerComplete. It has also licensed the PGDx Enterprise Solution platform, which enables laboratories to conduct their own advanced cancer genomic testing using next-generation sequencing.

In turn, Human Longevity will perform whole genome sequencing and analysis for select PGDx customers and for the firm's own research activities.

"Having access to PGDx's capabilities, targeted cancer panels, and Enterprise Solution platform for advanced cancer genomic testing is another important component to our already comprehensive and accurate database of human biological data," Craig Venter, co-founder and CEO of Human Longevity, said in a statement.

PGDx's services characterize genomic alterations in tumors using tissue and liquid biopsies from cancer patients. The firm's targeted gene panels focus on well-characterized genes that have been selected for their high biologic importance in cancer and their relevance to drug targets and pathways.

Financial and other terms of the agreement were not disclosed. 

The Scan

Time to Act

A new report urges the UK to consider regulations to protect against the misuse of genomic technologies, according to the Guardian.

Fulgent Seeking Defamation Suit

Fulgent Genetics says it plans to sue Los Angeles County Sheriff Alex Villanueva for defamation, the Los Angeles Times reports.

Speeding Gene-Edited Crops

Reuters reports that China's new trial rules will make it easier to grow gene-edited crops there.

Nucleic Acids Research Papers on Viral Recombination, Pan-Cancer Mutations, SARS-CoV-2 Variability

In Nucleic Acids Research this week: updated pipeline to detect viral recombination, mutational patterns in tumor samples, and more.